Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Anetta Undas

Showing results (421-430 of 652) with videos related to

Pageof 66
Sort By:
Advances in Clinical and Experimental Medicine : Official Organ Wroclaw Medical University|August 9, 2018
Non-classical and intermediate monocytes in patients following venous thromboembolism: Links with inflammationEwa Wypasek, Agnieszka Padjas, Magdalena Szymańska, et al.
Kardiologia Polska|September 29, 2009
Factor XIII Val34Leu polymorphism as a modulator of fibrin clot permeability and resistance to lysis in patients with severe coronary artery diseaseEwa Stepień, Dariusz Plicner, Bogusław Kapelak, et al.
Thrombosis and Haemostasis|June 2, 2017
Interplay between elevated cellular fibronectin and plasma fibrin clot properties in type 2 diabetesMałgorzata Konieczyńska, Agata Hanna Bryk, Krzysztof P Malinowski, et al.
Thrombosis Research|January 16, 2010
Prothrombinase formation at the site of microvascular injury and aspirin resistance: the effect of simvastatinAnetta Undas, Zbigniew Siudak, Kathleen Brummel-Ziedins, et al.
Blood Coagulation & Fibrinolysis : an International Journal in Haemostasis and Thrombosis|August 21, 2020
Interaction of glycated and acetylated human α2-antiplasmin with fibrin clotsAgata H Bryk, Dorota Satała, Joanna Natorska, et al.
Blood Coagulation & Fibrinolysis : an International Journal in Haemostasis and Thrombosis|April 14, 2012
Antithrombin Krakow II (c.624+1 G > T): a novel mutation leading to type 1 antithrombin deficiencyMagdalena Celinska-Löwenhoff, Teresa Iwaniec, Martine Alhenc-Gelas, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology|April 1, 2006
Plasma homocysteine affects fibrin clot permeability and resistance to lysis in human subjectsAnetta Undas, Jan Brozek, Milosz Jankowski, et al.
Medicina (Kaunas, Lithuania)|September 25, 2020
Novel Splice Site Mutation in the <i>PROS1</i> Gene in a Polish Patient with Venous Thromboembolism: c.602-2delA, Splice Acceptor Site of Exon 7Magdalena Mrożek, Ewa Wypasek, Martine Alhenc-Gelas, et al.
International Journal of Cardiology|November 21, 2022
Therapy with high-dose statins reduces soluble P-selectin: The impact on plasma fibrin clot propertiesJakub Siudut, Joanna Pudło, Małgorzata Konieczyńska, et al.
Clinical and Experimental Rheumatology|February 24, 2017
Neutrophil extracellular traps formation in patients with eosinophilic granulomatosis with polyangiitis: association with eosinophilic inflammationJoanna Natorska, Michał Ząbczyk, Jakub Siudut, et al.
Pageof 66

Showing results (421-430 of 652) with videos related to

Sort By:
Pageof 66
Advances in Clinical and Experimental Medicine : Official Organ Wroclaw Medical University|August 9, 2018
Non-classical and intermediate monocytes in patients following venous thromboembolism: Links with inflammationEwa Wypasek, Agnieszka Padjas, Magdalena Szymańska, et al.
Kardiologia Polska|September 29, 2009
Factor XIII Val34Leu polymorphism as a modulator of fibrin clot permeability and resistance to lysis in patients with severe coronary artery diseaseEwa Stepień, Dariusz Plicner, Bogusław Kapelak, et al.
Thrombosis and Haemostasis|June 2, 2017
Interplay between elevated cellular fibronectin and plasma fibrin clot properties in type 2 diabetesMałgorzata Konieczyńska, Agata Hanna Bryk, Krzysztof P Malinowski, et al.
Thrombosis Research|January 16, 2010
Prothrombinase formation at the site of microvascular injury and aspirin resistance: the effect of simvastatinAnetta Undas, Zbigniew Siudak, Kathleen Brummel-Ziedins, et al.
Blood Coagulation & Fibrinolysis : an International Journal in Haemostasis and Thrombosis|August 21, 2020
Interaction of glycated and acetylated human α2-antiplasmin with fibrin clotsAgata H Bryk, Dorota Satała, Joanna Natorska, et al.
Blood Coagulation & Fibrinolysis : an International Journal in Haemostasis and Thrombosis|April 14, 2012
Antithrombin Krakow II (c.624+1 G > T): a novel mutation leading to type 1 antithrombin deficiencyMagdalena Celinska-Löwenhoff, Teresa Iwaniec, Martine Alhenc-Gelas, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology|April 1, 2006
Plasma homocysteine affects fibrin clot permeability and resistance to lysis in human subjectsAnetta Undas, Jan Brozek, Milosz Jankowski, et al.
Medicina (Kaunas, Lithuania)|September 25, 2020
Novel Splice Site Mutation in the <i>PROS1</i> Gene in a Polish Patient with Venous Thromboembolism: c.602-2delA, Splice Acceptor Site of Exon 7Magdalena Mrożek, Ewa Wypasek, Martine Alhenc-Gelas, et al.
International Journal of Cardiology|November 21, 2022
Therapy with high-dose statins reduces soluble P-selectin: The impact on plasma fibrin clot propertiesJakub Siudut, Joanna Pudło, Małgorzata Konieczyńska, et al.
Clinical and Experimental Rheumatology|February 24, 2017
Neutrophil extracellular traps formation in patients with eosinophilic granulomatosis with polyangiitis: association with eosinophilic inflammationJoanna Natorska, Michał Ząbczyk, Jakub Siudut, et al.
Pageof 66